ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,060Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 2094

$1.51M Total Retail Price of All Prescriptions

Rank: 24 out of 2094

565 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

2% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

3% of this provider’s 14,047 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 804 610 1 1
OMEPRAZOLE 686 528 2 4
METOPROLOL SUCCINATE 490 357 3 9
AMLODIPINE BESYLATE-BENAZEPRIL 488 404 4 58
LEVOTHYROXINE SODIUM 476 350 5 3
AMLODIPINE BESYLATE 461 411 6 2
ZOLPIDEM TARTRATE 440 266 7 14
JANUMET 400 282 8 86
NAMENDA 353 328 9 32
LOSARTAN POTASSIUM 326 244 10 17
METFORMIN HCL 304 185 11 8
GLYBURIDE-METFORMIN HCL 297 229 R 12 94
JANUVIA 280 222 13 35
NAPROXEN 264 189 14 84
FUROSEMIDE 240 172 15 6
ATORVASTATIN CALCIUM 226 177 16 5
CRESTOR 224 186 17 15
LISINOPRIL 213 163 18 7
GABAPENTIN 202 122 19 23
ENALAPRIL MALEATE 200 134 20 25
CARVEDILOL 193 169 21 19
CELEBREX 192 178 22 74
HYDROCHLOROTHIAZIDE 188 151 23 12
ALENDRONATE SODIUM 177 173 24 30
TAMSULOSIN HCL 173 140 25 29
NEXIUM 171 139 26 16
MELOXICAM 171 146 26 49
PROAIR HFA 171 98 26 45
CLOPIDOGREL 170 137 29 22
DIOVAN 165 115 30 13
GLIMEPIRIDE 158 118 31 31
POLYETHYLENE GLYCOL 3350 153 95 32 75
EXELON 153 140 32 111
METOPROLOL TARTRATE 153 143 32 10
DIOVAN HCT 151 135 35 28
POTASSIUM CHLORIDE 150 128 36 24
VENTOLIN HFA 147 77 37 132
ADVAIR DISKUS 146 89 38 36
LANTUS SOLOSTAR 143 91 39 76
DONEPEZIL HCL 141 133 40 20
VOLTAREN 139 112 41 109
NIFEDIPINE ER 138 123 42 96
CYCLOBENZAPRINE HCL 137 50 R 43 115
FLUTICASONE PROPIONATE 130 98 44 41
AZITHROMYCIN 129 88 45 27
PLAVIX 123 108 46 38
LACTULOSE 123 88 46 65
CIPROFLOXACIN HCL 118 75 48 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 74 49 55
CLOTRIMAZOLE-BETAMETHASONE 115 83 50 91
OXYCODONE-ACETAMINOPHEN 108 32 S2 51 40
LOSARTAN-HYDROCHLOROTHIAZIDE 105 94 52 52
ZETIA 104 70 53 79
EVISTA 103 103 54 131
TRAMADOL HCL-ACETAMINOPHEN 102 71 55 100
FAMOTIDINE 101 87 56 34
OXYCODONE HCL 98 13 S2 57 63
LYRICA 97 50 58 85
LOVAZA 96 68 59 53
SINGULAIR 87 59 60 64
DICLOFENAC SODIUM 87 61 60 168
LIDODERM 83 54 62 59
SYMBICORT 82 45 63 149
IBANDRONATE SODIUM 81 80 64 140
TORSEMIDE 79 65 65 118
AMITIZA 78 61 66 239
DEXILANT 78 78 66 124
EXFORGE 76 74 68 105
AVODART 76 67 68 163
BUPROPION XL 75 26 70 249
PATANOL 75 43 70 198
CLOBETASOL PROPIONATE 72 62 72 160
UNIFINE PENTIPS 70 39 73 257
ATENOLOL 67 49 74 21
PAROXETINE HCL 64 40 75 77
PRAVASTATIN SODIUM 64 44 75 18
TRAMADOL HCL 64 43 75 33
ENDOCET 63 13 S2 78 88
LEVOFLOXACIN 60 45 79 70
SERTRALINE HCL 60 46 79 26
BENICAR HCT 58 36 81 133
WELCHOL 57 39 82 146
FLOVENT HFA 57 21 82 242
MEGESTROL ACETATE 54 48 R 84 174
DIGOXIN 53 29 85 51
GLIPIZIDE ER 53 25 85 126
CYMBALTA 53 36 85 61
SOLARAZE 53 37 85 278
LEVOCETIRIZINE DIHYDROCHLORIDE 51 40 89 169
ACTOS 50 36 90 112
SPIRIVA 50 43 90 60
ISOSORBIDE MONONITRATE ER 50 41 90 57
PROCTOZONE-HC 50 43 90 266
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.